Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-20

Clinical Trial Update: Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating two combination regimens for advanced breast cancer (pemetrexed-carboplatin and gemcitabine-vinorelbine) has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alimta (pemetrexed)
  • Gemzar (gemcitabine)
  • Navelbine (vinorelbine)
  • Paraplatin (Carboplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-20